|Researchers Jennifer Cochran and Amato Giaccia from Stanford University have recently made a breakthrough in cancer research. The Bioengineers have developed a synthetic form of the protein Axls that binds to the protein Gas6 in our blood. Cancerous cells have Axls proteins lining the cell membrane awaiting connections with Gas6 proteins. Once the two join together, the cancerous cells break away from the central cancer mass and spread through the body during a process known as Metastasis. However, the new synthetic Axls protein binds to Gas6 in the blood and inhibits Metastasis from ever beginning. This stops the original Axls cells on the cancer from receiving the chemical signals to break away and form new cancerous nodules.|
The scientists conducted preliminary testing on lab mice with aggressive forms of ovarian and breast cancer. The Bioengineers found that, “Mice in the breast cancer treatment group had 78 percent fewer metastatic nodules than untreated mice. Mice with ovarian cancer had a 90 percent reduction in metastatic nodules when treated with the engineered decoy protein.” Scientists currently treat cancers with chemotherapy and radiation, however these early studies show that the synthetic protein Axls could prove to be a safe and effective alternative.
I believe that this type of Bioengineering, specifically directed evolution, holds the key to discovering cures for many of earth’s deadly diseases. Despite the recent breakthrough researchers have made at Stanford, it will still be years before synthetic Axls is approved for clinical studies and then for use in the medical field.
Original Article: http://www.sciencedaily.com/releases/2014/09/140921145112.htm